Expression and Purification of Human Farnesoid X Receptor-Ligand Binding Domain as Soluble Form Using a Dual Cistronic Expression Vector

被引:1
|
作者
Kang, Hyun [1 ]
Ye, Micheal B. [2 ]
Bahk, Young Yil [1 ]
机构
[1] Konkuk Univ, Dept Biotechnol, Coll Biomed & Hlth Sci, Chungju City 380701, South Korea
[2] Konkuk Univ, Dept Appl Biochem, Coll Biomed & Hlth Sci, Chungju City 380701, South Korea
关键词
Nuclear receptor; recombinant FXR-LBD; dual expression vector; E. coli expression system; NUCLEAR RECEPTOR; IDENTIFICATION; POLARIZATION; STRATEGIES; GENES; ASSAY;
D O I
10.4014/jmb.1212.12014
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In this study, we show the expression and purification of the human recombinant farnesoid X receptor (FXR)-ligand binding domain (LBD) protein in E. coli using a double cistronic vector, pACYCDuet-1, as a soluble form. We describe here the expression and characterization of a biologically active FXR-LBD(248-476). When expressed in the influence of bacterial promoters (P-T7 and P-Tac) of the single cistronic expression vectors, the human recombinant FXR-LBD(248-476) was found to be totally insoluble. However, by using a double cistronic expression vector, we were able to obtain the human recombinant FXR-LBD(248-476) in a soluble form. To allow for biological activities, we have subcloned into the pACYCDuet-1 vector, expressed in E. coli cells at some optimized conditions, and purified and characterized the human recombinant active FXR-LBD(248-476) proteins using the fluorescence polarization assay. This suggests that the expression of FXR-LBD in a double cistronic vector improves its solubility and probably assists its correct folding for the biologically active form of the proteins. We suggest that this may represent a new approach to high expression of other nuclear receptors and may be useful as well for other classes of heterodimeric protein partners.
引用
收藏
页码:322 / 328
页数:7
相关论文
共 50 条
  • [1] Heterologous expression and purification of the ligand binding domain of estrogen receptor β
    Shi, Guoqing
    Guo, Yanfeng
    Wei, Wei
    Song, Qing
    Zhang, Huai
    Zhong, Guangrong
    Beijing Keji Daxue Xuebao/Journal of University of Science and Technology Beijing, 2007, 29 (SUPPL. 2): : 208 - 211
  • [2] HUMAN FORMYL PEPTIDE RECEPTOR-LIGAND BINDING DOMAIN(S) - STUDIES USING AN IMPROVED MUTAGENESIS/EXPRESSION VECTOR REVEAL A NOVEL MECHANISM FOR THE REGULATION OF RECEPTOR OCCUPANCY
    PEREZ, HD
    VILANDER, L
    ANDREWS, WH
    HOLMES, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (36) : 22485 - 22487
  • [3] Structural study of retinoid x receptor-ligand binding domain
    Hammond, Ebony
    Jablonsky, Michael J.
    Muccio, Donald D.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [4] Soluble Expression and Affinity Purification of Functional Domain of Human Acetylcholine Receptor α-subunit by the Modulation of Maltose Binding Protein
    Zhuo-Yu Li
    Yan-Jun Li
    Chen-Yun Guo
    Ye-Wei Shi
    Ming-Qun Xu
    Wolfgang E. Trommer
    Jing-Ming Yuan
    Biotechnology Letters, 2004, 26 : 1765 - 1769
  • [5] Soluble expression and affinity purification of functional domain of human acetylcholine receptor α-subunit by the modulation of maltose binding protein
    Li, ZY
    Li, YJ
    Guo, CY
    Shi, YW
    Xu, MQ
    Trommer, WE
    Yuan, JM
    BIOTECHNOLOGY LETTERS, 2004, 26 (23) : 1765 - 1769
  • [6] Synthesis and purification of soluble ligand binding domain of the human vitamin D-3 receptor
    Craig, TA
    Kumar, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 218 (03) : 902 - 907
  • [7] Enhanced expression of farnesoid X receptor in human hepatocellular carcinoma
    Kumagai, Arisa
    Fukushima, Junichi
    Takikawa, Hajime
    Fukuda, Toshio
    Fukusato, Toshio
    HEPATOLOGY RESEARCH, 2013, 43 (09) : 959 - 969
  • [8] Recognition of LXXLL by ligand binding domain of the Farnesoid X receptor in molecular dynamics simulation
    Zhang, Tao
    Dong, Xi-Cheng
    Chen, Min-Bo
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (06) : 2623 - 2630
  • [9] Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor
    Perrin, MH
    Fischer, WH
    Kunitake, KS
    Craig, AG
    Koerber, SC
    Cervini, LA
    Rivier, JE
    Groppe, JC
    Greenwald, J
    Nielsen, SM
    Vale, WW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) : 31528 - 31534
  • [10] Recombinant expression of the Ah receptor ligand binding domain
    Jiang, T
    Bell, DR
    TOXICOLOGY, 2004, 194 (03) : 259 - 259